Dartmouth-Hitchcock Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Dartmouth-Hitchcock Medical Center sits in the top decile of US sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count).
Dartmouth-Hitchcock Medical Center: 427 sponsored US clinical trials, 52 recruiting.
Dartmouth-Hitchcock Medical Center sponsors 427 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 300 completed. 25 of these trials are in Phase 3-4 (later-stage) and 84 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 12 trials.
Top-decile sponsor footprint
Dartmouth-Hitchcock Medical Center ranks in the top decile of sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
300 of 352 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
427 total, page 4 of 9
Use of Brain Wave Monitoring During Surgery to Reduce Postoperative Cognitive Dysfunction
NCT04189861
A Survey of Financial Toxicity in Rural Cancer Patients
NCT04032483
Early Chimerism Following Allogeneic Stem-Cell Transplant
NCT03689907
Nudging Healthcare Organizations to Adopt New Care Delivery Practices
NCT04176146
An Intraoperative Guidance Platform for Radio Frequency Ablation
NCT04152343
Measuring and Improving Coproduction Using coopeRATE
NCT04060329
Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis
NCT03805737
Feasibility of Insomnia Tracking and Treatment in IBD
NCT04132024
Creative Arts II Study
NCT03994718
IMPROVE AKI Cluster-Randomized Trial
NCT03556293
Evaluating Right Ventricular (RV) Size and Function Using the Upper Valley RV Algorithm and Novel Imaging Modalities
NCT03935178
Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings
NCT03985449
Evaluation of the Healthy Lifestyle Program on Cognitive Outcomes
NCT03926481
Variation in Cancer Centers' End-of-Life Quality
NCT03780816
LoveYourBrain Yoga for Multiple Sclerosis
NCT03827928
Trial on the Effect of Media Multi-tasking on Attention to Food Cues and Cued Overeating
NCT03882957
ICG Fluorescence Imaging in Trauma Patients
NCT04245111
Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT
NCT03689894
Hybrid Trial of Brief Cognitive-Behavioral Therapy for Health Anxiety in Primary Care
NCT03789084
VR-Based Physical Therapy Pilot Study
NCT03779425
Using Mobile Technology to Improve Self-Regulation
NCT03774433
Somatosensory Profiles in Individuals With Persistent Musculoskeletal Pain and Inflammatory Bowel Disease
NCT03799471
Neurology Inpatient Clinical Education Trial
NCT03826056
Sleep During Weight Loss and Weight Loss Maintenance
NCT03774563
Stoma Closure and Reinforcement Trial
NCT03750461
HPV Message Testing and Social Media Campaign
NCT03747302
HEARt Sounds: Audio Recordings to Improve Discharge Communication for Cardiology Inpatients
NCT03735342
The Excess Opioid Disposal Study
NCT03694899
MOWI Home-Based Pilot
NCT03104205
Project UPLIFT for Psychogenic Non-Epileptic Seizures
NCT03329703
The Prone to Supine Breast MRI Trial
NCT03573804
Foundations of Fitness Program Pilot
NCT03622086
A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation (REM)
NCT03500393
A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers
NCT03573661
Metformin Pharmacology in Human Cancers: A Proof of Principle Study
NCT03477162
Improving Sleep in Cancer Patients: A Feasibility Trial
NCT03561064
Family Planning Ahead
NCT03500952
Medical Qigong for Mobility and Balance Self-Confidence
NCT04430751
A Study of BNC105P Combined With Ibrutinib
NCT03454165
Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity
NCT03348956
High-density EEG in Neurological Disorders
NCT04266041
Noninvasive Monitoring in Lower Body Negative and Positive Pressure Tests
NCT03671902
A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery
NCT03282461
Using Mobile Technology to Better Understand and Measure Self-Regulation
NCT03352713
Health Coaching & Technology in a Weight Loss Center
NCT03309787
A Pilot Study of Creative Arts Interventions for Neurology Inpatients
NCT03520777
What Matters Most: Choosing the Right Breast Cancer Surgery for You
NCT03136367
A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer Surgery
NCT03162718
Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares
NCT03494764
MOWI Research Pilot
NCT03104192
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 44 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the Dartmouth-Hitchcock Medical Center pipeline
52 recruiting of 427 indexed (12% open); 300 completed (70%).
Phase mix: 25 late (III/IV) vs 84 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Dartmouth-Hitchcock Medical Center: open-pipeline peers nationwide
Peers matched on 427 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Dartmouth-Hitchcock Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 427 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Friends Research Institute · 12% recruiting · 41 trials
- Antonios Likourezos · 12% recruiting · 33 trials
- Oregon State University · 12% recruiting · 33 trials
- University of Massachusetts, Amherst · 12% recruiting · 33 trials
Related
What to do with this Dartmouth-Hitchcock Medical Center page
427 registered trials is a research-attention snapshot, not an endorsement of Dartmouth-Hitchcock Medical Center or any single study.
- 52 of Dartmouth-Hitchcock Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Dartmouth-Hitchcock Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Dartmouth-Hitchcock Medical Center pipeline card: 427 registered trials from official public datasets.Report a data error.